OXYCODONE AND ACETAMINOPHEN Drug Patent Profile
✉ Email this page to a colleague
When do Oxycodone And Acetaminophen patents expire, and when can generic versions of Oxycodone And Acetaminophen launch?
Oxycodone And Acetaminophen is a drug marketed by Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart, Nostrum Labs Inc, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Ascent Pharms Inc, Aurolife Pharma Llc, Cerovene Inc, Chartwell, Dr Reddys Labs Sa, Epic Pharma Llc, Granules, Lannett Co Inc, Nesher Pharms, Novel Labs Inc, Rhodes Pharms, Sun Pharm Inds Inc, and Wes Pharma Inc. and is included in fifty-one NDAs.
The generic ingredient in OXYCODONE AND ACETAMINOPHEN is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
Summary for OXYCODONE AND ACETAMINOPHEN
US Patents: | 0 |
Applicants: | 29 |
NDAs: | 51 |
Finished Product Suppliers / Packagers: | 35 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 140 |
Patent Applications: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OXYCODONE AND ACETAMINOPHEN at DailyMed |

Recent Clinical Trials for OXYCODONE AND ACETAMINOPHEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ciusss de L'Est de l'Île de Montréal | N/A |
Lee A. Kral | Phase 4 |
University of Tennessee | Phase 4 |
Pharmacology for OXYCODONE AND ACETAMINOPHEN
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |